XClose

UCL News

Home
Menu

Mother seeks immunotherapy for cervical cancer

18 March 2019

A study led by Professor Tim Meyer (UCL Cancer Institute) which found the immunotherapy drug Nivolumab to be effective for a quarter of patients with advanced cervical cancer is referenced in an article about a mother seeking funds for treatment.

Read: Mirror